- Kondo Y, Hamai J, Nezu U, Shigematsu E, Kamiko K, Yamazaki S, Takahashi M, Takano T, Kawasaki S, Yamada M, Yamakawa T, Terauchi Y. Second-line treatments in dyslipidemic patients at risk of cardiovascular disease.Endocr J, 61(4): 343-51, 2014.
- Togashi Y, Shirakawa J, Orime K, Kaji M, Sakamoto E, Tajima K, Inoue H, Nakamura A, Tochino Y, Goshima Y, Shimomura I, Terauchi Y. β cell proliferation after a partial pancreatectomy is independent of IRS-2 in mice.Endocrinology, 155(5), 1643-52.2014.
- Shirakawa J, Terauchi Y. Selective and sequential loss of transcriptional factors: a hallmark of β cell failure in type 2 diabetes? Diabetes Invest, 5(4):359-61, 2014. [Review]
- Yamakawa T, Ogihara K, Utsunomiya H, Muraoka T, Kadonosono K, Terauchi Y. Colestimide improve glycemic control via hepatic glucose production in db/db mice.Endocr J, 61(5): 425-36, 2014.
- Takai M, Ishikawa M, Maeda H, Kanamori A, Kubota A, Amemiya H, Iizuka T, Iemitsu K, Iwasaki T, Uehara G, Umezawa S, Obana M, Kaneshige H, Kaneshiro M, Kawata T, Sasai N, Saito T, Takuma T, Takeda H, Tanaka K, Tsurui N, Nakajima S, Hoshino K, Honda S, Machimura H, Matoba K, Minagawa F, Minami N, Miyairi Y, Mokubo A, Motomiya T, Waseda M, Miyakawa M, Naka Y, Terauchi Y, Tanaka Y, Matsuba I. Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study.Diabetes Res Clin Pract. 103(3): e30-3, 2014.
- Tanizawa Y, Kaku K, Araki E, Tobe K, Terauchi Y, Utsunomiya K, Iwamoto Y, Watada H, Ohtsuka W, Watanabe D, Suganami H; for the Tofogliflozin 004 and 005 Study group. Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials.Expert Opin Pharmacother. 15(6):749-66, 2014.
- Kawata T, Kanamori A, Kubota A, Maeda H, Amamiya H, Takai M, Kaneshige H, Minagawa F, Iemitsu K, Kaneshiro M, Ishikawa M, Takeda H, Takuma T, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Suzuki D, Terauchi Y, Toyoda M, Tanaka Y, Matsuba I. Is a switch from insulin therapy to liraglutide possible in Japanese type 2 diabetes mellitus patients?J Clin Med Res. 6(2):138-44, 2014.
- Shirakawa J, Okuyama T, Yoshida E, Shimizu M, Horigome Y, Tuno T, Hayasaka M, Abe S, Fuse M, Togashi Y, Terauchi Y. Effects of the antitumor drug OSI-906, a dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β cell functions, and β cell proliferation in male miceEndocrinology, 155(6): 2102-11, 2014.
- Inoue K, Tsujimoto T, Yamamoto-Honda R, Goto A, Kishimoto M, Noto H, Kajio H, Doi S, Miyazaki S, Terauchi Y, Noda M. A newer conversion equation for the correlation between HbA1c and glycated albumin.Endocr J. 61(6): 553-60, 2014.
- Kaku K, Watada H, Iwamoto Y, Utsunomiya K, Terauchi Y, Tobe K, Tanizawa Y, Araki E, Ueda M, Suganami H, Watanabe D. Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study.Cardiovasc Diabetol. 28;13(1): 65, 2014.
- Kamiyama H, Aoki K, Nakajima S, Shinoda K, Kamiko K, Taguri M, Terauchi Y. Effect of repaglinide therapy administered twice or thrice daily for 3 months on glycemic control in Japanese patients with type 2 diabetes.J Int Med Res. 42(5):1150-60, 2014.
- Terauchi Y, Satoi Y, Takeuchi M, Imaoka T. Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study.Endocr. J. 61(10):949-59, 2014.
- Kadowaki T, Haneda M, Inagaki N, Terauchi Y, Taniguchi A, Koiwai K, Rattunde H, Woerle HJ, Broedl UC. Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial.Adv Ther. 31(6): 621-38, 2014.
- Miyazaki Y, Yusa T, Matsuo S, Terauchi Y, Miyazaki S. Zyxin modulates the transmigration of Haemophilus influenzae to the central nervous system.Virulence. 5(6): 665-72, 2014.
- Shirakawa J, Murohashi Y, Okazaki N, Yamazaki S, Tamura T, Okuyama T, Togashi Y, Terauchi Y. Using miglitol at 30 min before meal is effective in hyperinsulinemic hypoglycemia after a total gastrectomy.Endocr. J. 61(11): 1115-23, 2014.
- Sato K, Satoh S, Muraoka T, Miyazaki Y, Kikuchi K, Terauchi Y. Evidence of brain atrophy detected on magnetic resonance imaging is associated with failure of acquisition of the ability for insulin self-injection. Endocr. J. 61(11): 1125-30, 2014.
- Shigematsu E, Yamakawa T, Kadonosono K, Terauchi Y. Effect of sitagliptin on lipid profile in patients with type 2 diabetes mellitus. J Clin Med Res. 6(5): 327-35, 2014.
- Kamiko K, Aoki K, Kamiyama H, Taguri M, Shibata E, Ashiya Y, Minagawa F, Shinoda K, Nakajima S, Terauchi Y. Comparison of the administration of teneligliptin every day versus every other day in Japanese patients with type 2 diabetes: A randomized non-inferior test.J Clin Pharmacol. 2014 Aug 27. doi: 10.1002/jcph.385. [Epub ahead of print]
- Nakamura A, Yoneda M, Sumida Y, Miyoshi H, Nakajima A, Atsumi T, Terauchi Y. A caution in the use of the NAFIC scoring system as a diagnostic screening tool for nonalcoholic steatohepatitis.Gastrointestinal Digestive System. in press, 2014.
- Nakamura A, Terauchi Y. Present status of clinical deployment of glucokinase activators.J Diabetes Investig. in press, 2014. [Review]
